Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Lymphoma, Large B-Cell, Diffuse 15Burkitt Lymphoma 14Lymphoma, Mantle-Cell 13Precursor Cell Lymphoblastic Leukemia-Lymphoma 10Leukemia, Lymphocytic, Chronic, B-Cell 8Lymphoma, Follicular 6Lymphoma, B-Cell, Marginal Zone 6Lymphoma, B-Cell 5Lymphoma, Non-Hodgkin 4Lymphoma 4Leukemia, Myeloid, Accelerated Phase 4Waldenstrom Macroglobulinemia 3Leukemia, Myelomonocytic, Chronic 3Leukemia, Biphenotypic, Acute 3Hodgkin Disease 3Myelodysplastic Syndromes 2Leukemia, Myeloid, Acute 2Blast Crisis 2Anemia, Refractory, with Excess of Blasts 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1Neoplasm, Residual 1Myelodysplastic-Myeloproliferative Diseases 1Lymphoma, T-Cell 1Leukemia, Prolymphocytic 1Leukemia, Myeloid, Chronic-Phase 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia, Lymphoid 1Leukemia, Hairy Cell 1Histiocytosis, Langerhans-Cell 1

Interventions

Rituximab 12Tacrolimus 11Peripheral Blood Stem Cell Transplantation 10Mycophenolic Acid 9fludarabine phosphate 8Cyclophosphamide 8Whole-Body Irradiation 6Methotrexate 5Cyclosporine 5Antilymphocyte Serum 5Vemurafenib 4Methylprednisolone 4Cladribine 4Busulfan 4merphos 3Therapeutics 3Radiotherapy 3Alemtuzumab 3obinutuzumab 2ibrutinib 2fludarabine 2binimetinib 2aldesleukin 2Transplantation 2Specimen Handling 2Prednisone 2Melphalan 2Lenalidomide 2Interferon-alpha 2Filgrastim 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Leukemia, Hairy Cell × CT-P10 × Clear all
NCT00412594 2025-12-22

Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia

M.D. Anderson Cancer Center

Phase 2 Recruiting
150 enrolled
Other hematologic neoplasm

Leukemia, Hairy Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡